Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion-induced apoptosis by bcl-2-mitochondria-ROS-iNOS pathway
- 554 Downloads
The aim of present study is to explore the cytoprotection of curcumin against 1-methyl-4-phenylpridinium ions (MPP+)-induced apoptosis and the molecular mechanisms underlying in PC12 cells. Our findings indicated that MPP+ significantly reduced the cell viability and induced apoptosis of PC12 cells. Curcumin protected PC12 cells against MPP+-induced cytotoxicity and apoptosis not only by inducing overexpression of Bcl-2, but also reducing the loss of mitochondrial membrane potential (MMP), an increase in intracellular reactive oxygen species (ROS) and overexpression of inducible nitric oxide synthase (iNOS). The selective iNOS inhibitor AG partly blocked MPP+-induced apoptosis of PC12 cells. The results of present study suggested that the cytoprotective effects of curcumin might be mediated, at least in part, by the Bcl-2-mitochondria-ROS-iNOS pathway. Because of its non-toxic property, curcumin could be further developed to treat the neurodegenerative diseases which are associated with oxidative stress, such as Parkinson’s disease (PD).
Keywordsapoptosis bcl-2 curcumin cytoprotection iNOS
Unable to display preview. Download preview PDF.
- 1.Fahn S. Parkinsonism. In: Wyngaarden JB, Smith JR LH, ed. Cecil’s Textbook of Medicine. Philadelphia, PA: Saunders 1988; 2143–2147.Google Scholar
- 9.Nadkarni KM. Indian material media. In: Nadkarni KM, ed. Bombay: Popular Prakashan 1976; 414–417.Google Scholar
- 23.Qing H, Xu H, Wei Z, Gibson K, Li XM. The ability of atypical antipsychotic drugs vs. haloperidol to protect PC12 cells against MPP+-induced apoptosis. Eur J Neurosci 2003; 17(8): 1563–1570.Google Scholar
- 32.Wu LY, Ding AS, Zhao T, Ma ZM, Wang FZ, Fan M. Involvement of increased stability of mitochondrial membrane potential and overexpression of Bcl-2 in enhanced anoxic tolerance induced by hypoxic preconditioning in cultured hypothalamic neurons. Brain Res 2004; 999(2): 149–154.PubMedCrossRefGoogle Scholar